BioCryst Pharmaceuticals shares owned by Sarissa Capital Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Sarissa Capital Management
from 13F filings
Historical chart of Sarissa Capital Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Sarissa Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.0M | 1.0M | 5.99 |
| 2023-09-30 | $5.5M | 775k | 7.08 |
| 2023-06-30 | $5.5M | 775k | 7.04 |
| 2023-03-31 | $6.5M | 775k | 8.34 |
| 2022-12-31 | $11M | 980k | 11.48 |
| 2022-09-30 | $18M | 1.4M | 12.60 |
| 2022-06-30 | $15M | 1.4M | 10.58 |
| 2022-03-31 | $23M | 1.4M | 16.26 |
| 2021-12-31 | $56M | 4.0M | 13.85 |
| 2021-09-30 | $56M | 3.9M | 14.37 |
| 2021-06-30 | $67M | 4.3M | 15.81 |
| 2021-03-31 | $78M | 7.6M | 10.17 |
| 2020-12-31 | $61M | 8.2M | 7.45 |
| 2020-09-30 | $17M | 4.9M | 3.43 |
| 2020-06-30 | $5.1M | 1.1M | 4.76 |
More positions owned by Sarissa Capital Management
View all positions for Sarissa Capital Management